Awards for “TEVA PHARMACEUTICALS USA, INC.”
25 awards on this page · sorted by amount · page 14
| Award ID | Recipient | Awarding agency | Amount | Start | End | NAICS | Description |
|---|---|---|---|---|---|---|---|
| SPE2DP22F6744 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $293.65K | 2022-08-18 | 2022-08-30 | 325412 | 8509324190!ADENOVIRUS TYPE 4 A |
| SPE2DP22F6742 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $293.65K | 2022-08-18 | 2022-08-30 | 325412 | 8509324136!ADENOVIRUS TYPE 4 A |
| SPE2DP22F6740 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $293.65K | 2022-08-18 | 2022-08-30 | 325412 | 8509324132!ADENOVIRUS TYPE 4 A |
| SPE2DP22F6739 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $293.65K | 2022-08-18 | 2022-08-30 | 325412 | 8509324057!ADENOVIRUS TYPE 4 A |
| SPE2DP22F6115 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $293.65K | 2022-07-18 | 2022-07-26 | 325412 | 8509243578!ADENOVIRUS TYPE 4 A |
| SPE2DP22F6108 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $293.65K | 2022-07-18 | 2022-07-26 | 325412 | 8509243087!ADENOVIRUS TYPE 4 A |
| SPE2DP22F6107 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $293.65K | 2022-07-18 | 2022-07-26 | 325412 | 8509243085!ADENOVIRUS TYPE 4 A |
| SPE2DP22F5155 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $293.65K | 2022-06-15 | 2022-06-28 | 325412 | 8509165129!ADENOVIRUS TYPE 4 A |
| SPE2DP22F5152 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $293.65K | 2022-06-14 | 2022-06-28 | 325412 | 8509165028!ADENOVIRUS TYPE 4 A |
| SPE2DP22F5148 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $293.65K | 2022-06-14 | 2022-06-28 | 325412 | 8509164525!ADENOVIRUS TYPE 4 A |
| SPE2DP22F4655 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $293.65K | 2022-05-17 | 2022-05-24 | 325412 | 8509105233!ADENOVIRUS TYPE 4 A |
| SPE2DP22F4652 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $293.65K | 2022-05-17 | 2022-05-24 | 325412 | 8509105129!ADENOVIRUS TYPE 4 A |
| SPE2DP22F4650 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $293.65K | 2022-05-17 | 2022-05-24 | 325412 | 8509105122!ADENOVIRUS TYPE 4 A |
| SPE2DP22F4649 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $293.65K | 2022-05-17 | 2022-05-24 | 325412 | 8509105120!ADENOVIRUS TYPE 4 A |
| SPE2DP22F4079 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $293.65K | 2022-04-19 | 2022-04-26 | 325412 | 8509034851!ADENOVIRUS TYPE 4 A |
| SPE2DP22F4075 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $293.65K | 2022-04-19 | 2022-04-26 | 325412 | 8509034737!ADENOVIRUS TYPE 4 A |
| SPE2DP22F4074 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $293.65K | 2022-04-19 | 2022-04-26 | 325412 | 8509034731!ADENOVIRUS TYPE 4 A |
| SPE2DP22F4072 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $293.65K | 2022-04-19 | 2022-04-26 | 325412 | 8509034525!ADENOVIRUS TYPE 4 A |
| SPE2DP22F3547 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $293.65K | 2022-03-22 | 2022-03-29 | 325412 | 8508961381!ADENOVIRUS TYPE 4 A |
| SPE2DP22F3538 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $293.65K | 2022-03-22 | 2022-03-29 | 325412 | 8508961299!ADENOVIRUS TYPE 4 A |
| SPE2DP22F3536 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $293.65K | 2022-03-22 | 2022-03-29 | 325412 | 8508961296!ADENOVIRUS TYPE 4 A |
| SPE2DP22F3535 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $293.65K | 2022-03-22 | 2022-03-29 | 325412 | 8508961294!ADENOVIRUS TYPE 4 A |
| SPE2DP22F3533 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $293.65K | 2022-03-22 | 2022-03-29 | 325412 | 8508961204!ADENOVIRUS TYPE 4 A |
| SPE2DP22F2574 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $293.65K | 2022-02-10 | 2022-03-01 | 325412 | 8508862674!ADENOVIRUS TYPE 4 A |
| SPE2DP22F2570 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $293.65K | 2022-02-10 | 2022-03-01 | 325412 | 8508862278!ADENOVIRUS TYPE 4 A |